Longevity medicine's do-or-die moment

Jun 18, 2026 · 11:30 AM UTC · 0 reactions · 0 comments · 4 views

The world's first human trial of whether a drug can essentially make a person's cells younger sets up a reality check for one of the longevity field's most promising theories. Why it matters: The early-stage clinical trial will signal whether "cellular reprogramming" can be performed safely in humans, a prerequisite for any future claim that a treatment can slow or even reverse biological aging. The big picture: Attempts to prolong the human lifespan can refer to anything from better diet and ex

Original article

Axios

Read full at Axios →

Anonymous · no account needed

Discussion

0 comments

Longevity medicine's do-or-die moment

Discussion

More from Axios